Biotechnology News

March 7, 2012

CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare, a unit of GE (NYSE:GE) announced today it has reached an agreement to acquire Xcellerex, Inc. a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical...

March 7, 2012

ZURICH & AMSTERDAM--(BUSINESS WIRE)--Leading life science partnering event to be a springboard for cell therapy, regenerative medicine and other potentially life-saving advanced therapeutics in Europe

March 7, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Genesys BioLabs Launches Blood Test for the Early Detection of Lung Cancer - Expected to help physicians direct highest risk patients to CT Scans for early, lifesaving intervention.

March 7, 2012

MILAN & BOLOGNA, Italy--(BUSINESS WIRE)--bio-on has chosen to work with Techint Engineering & Construction to build plants for the production of PHAs bioplastic, 100% natural-biodegradable and made using waste materials from sugar beet...

March 7, 2012

SEOUL, South Korea & FAIR LAWN, N.J.--(BUSINESS WIRE)--Christopher Gallen has been named the new CEO of SK Biopharmaceuticals and SK Life Science.

March 7, 2012

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Life Sciences company nanoMR names Jim Macemon VP Product Development to oversee design and manufacture of disposable cassettes and medical device for blood culture market Pathogen Capture System.

March 7, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx announced that its Chief Executive Officer, Kinneret Savitsky, and its Vice President of Business Development, David Malek, will be presenting at the 2012 Annual Roth Growth Conference

March 7, 2012

EXTON, Pa.--(BUSINESS WIRE)--The LaunchTrends®: Dificid Wave 3 report, which measures product uptake and commercial effectiveness at six months post-launch, finds that approximately 40 percent of surveyed infectious disease (ID) specialists and...

March 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals, which develops therapies targeting key metalloenzymes, today announced Richard Katz has joined the company as Chief Business and Financial Officer.

March 7, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE AMEX: SNT) today announced that it has received Institutional Review Board approval and has finalized a clinical trial research agreement with the...

March 7, 2012

TEL-AVIV, Israel--(BUSINESS WIRE)--Procognia announced it signed a binding letter of intent with Beijing Cy-tech Biotech Company

March 7, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has agreed to buy out the software royalty...

March 7, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO) today announced that Co-Chairman Kenneth Aldrich and President and Chief Operating Officer Kurt May will be presenting at the 24th Annual Roth Conference on...

March 7, 2012

NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals launches Sulfacetamide Ophthalmic Ointment, 10%. Ointments have the advantage of maintaining ocularcontact contact time longer than eye drops.

March 7, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the bladder cancer market, nearly 80 percent of all new drug-treatment...

March 7, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Having identified a business need in the US for a flexible and high quality commercial packaging service provider, the Pharma Services business unit of Almac is proud to expand its established...

March 7, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today reported financial results for the year ended December 31, 2011 and provided a business update. “Transgenomic enjoyed a landmark year in 2011, with revenue growth quarter-over-...

March 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--In 2011 Zalicus made significant progress advancing product candidates in clinical development. In 2012 Zalicus will see the results of those studies and make important decisions on next steps.

March 7, 2012

BOSTON--(BUSINESS WIRE)--Leading emerging technology research firm Lux Research profiled 262 companies in the 4th quarter of 2011 as part of its ongoing intelligence and releases the top 10 innovative companies profiled.

March 7, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen Completes Growth Capital Financing
Proceeds to Support Continued Commercialization of Whole Genome Mapping Technology

March 7, 2012

SAN JOSE, Calif. & BROOKINGS, S.D.--(BUSINESS WIRE)--Chronix Biomedical is providing a breakthrough approach to the diagnosis, monitoring and management of a broad range of cancers and other conditions.

March 7, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported financial results for the fourth quarter and the year ended December 31, 2011. Celldex reported a net loss of $12.7 million, or ($0.29) per basic and...

March 7, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today introduced the TruSeq Amplicon - Cancer Panel, a highly multiplexed panel that will allow researchers to accurately sequence hundreds of the most relevant cancer loci, even in difficult...

March 7, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) today announced that David Stack, president and chief executive officer of Pacira Pharmaceuticals, is scheduled to present at the Barclays Capital Global Healthcare...

March 7, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced that Rottapharm Madaus Portugal has expanded its Customer Relationship Management (CRM) solutions with next generation Mobile Intelligence™ via SaaS for the company’s OTC...

March 7, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx announced today that a European patent has been granted claiming BL-1020's composition and its use for the treatment of schizophrenia.

March 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on...

March 7, 2012

LONDON--(BUSINESS WIRE)--Imprivata®, Inc., the leader in secure access and collaboration for healthcare, today announced that 91 English NHS Trusts, 4 of the Trusts in Northern Ireland and Scotland’s entire NHS system are using Imprivata OneSign...

March 7, 2012

NEW YORK & CASTRES, France--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) and Pierre Fabre Medicament today announced positive top-line results in a Phase III clinical trial of levomilnacipran, an investigational agent for the...

March 7, 2012

NOTTINGHAM, UK--(BUSINESS WIRE)--Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis business, announces its attendance at the forthcoming ArabLab Exhibition in Dubai from 26-29 March 2012 (Stand 645). Sales...

March 7, 2012

SINGAPORE--(BUSINESS WIRE)--AB SCIEX Opens New Asia Pacific Application and Training Centre In Singapore’s Biomedical Hub

March 7, 2012

DUBLIN, Calif.--(BUSINESS WIRE)--Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to partner Eisai for their supplemental New Drug Application (sNDA) for...

March 7, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--XY LLC (formerly XY Inc.), an innovative leader in the livestock reproduction industry and primary promoter for commercialization of sperm sexing technology in animals, was just awarded an $8.5 million dollar...

March 7, 2012

SEATTLE--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from two different investigational studies conducted to better understand the potential use of VICTRELIS™ (boceprevir), the...

March 6, 2012

TYLER, Texas--(BUSINESS WIRE)--Pernix-McCoven has been alleged to violate key patents regarding manufacturing the active form of folate. Related products are used for diabetic peripheral neuropathy, depression and memory loss

March 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced that the Company will be presenting at the Roth Capital Partners 24th Annual OC Growth Stock Conference on Tuesday, March 13 at 11:00 a.m. (PT)

March 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--First graph, first sentence of release should read: ...Wednesday, March 7, 2012. (sted: ...Thursday, March 7, 2012.). The corrected release reads: AMAG PHARMACEUTICALS, INC. TO HOST CONFERENCE CALL ON MARCH 7,...

March 6, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories Inc. (Nasdaq: CBRX) received a notice on March 6, 2012, from the Nasdaq Stock Market indicating that it no longer meets the minimum bid price requirement for continued listing on the Nasdaq...

March 6, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Dividend

March 6, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the Quad Study 102 results will be presented on a conference call on Wednesday, March 7, at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. The...

March 6, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the Barclays Capital 2012 Global Healthcare Conference in Miami. John F. Milligan, PhD, Gilead’s...

March 6, 2012

WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement of support for the Faster Access to Specialized Treatments (FAST) Act, H.R. 4132, which was introduced yesterday...

March 6, 2012

BETHESDA, Md.--(BUSINESS WIRE)--A recently published study in the journal Alimentary Pharmacology and Therapeutics, demonstrated the long-term safety and tolerability profiles of AMITIZA (lubiprostone) in IBS-C patients.

March 6, 2012

SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ:ACCL) today reported financial results for the quarter and full year ended December 31, 2011. Non-GAAP revenue for the quarter ended December 31, 2011 decreased $1.6 million to $40.8 million from...

March 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metabolix Reports Fourth Quarter and Full Year 2011 Financial Results and Provides Business Update

March 6, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

March 6, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Barclays Healthcare Conference

March 6, 2012

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH) today reported financial results for the fourth quarter and full year ended December 31, 2011. Financial Highlights: $15.4 million in fourth quarter 2011 net product...

March 6, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the fourth quarter and year ended December 31, 2011, on Tuesday March 13, 2012 at approximately 4:00 p.m. ET / 1:00 p.m. PT. The...